查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1212104

血漿分餾的全球市場

Plasma Fractionation
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

全球血漿分餾的市場規模在2022年估算為241億美金，在2022年～2030年的分析期間預計將以5.4％的年複合成長率增長，到2030年前達到367億美元。

本報告提供全球血漿分餾市場調查，提供市場概要，市場促進因素的分析，市場機會，各地區的市場分析，競爭情形，主要企業的簡介等系統性資訊。

目錄

第1章 調查手法

第2章 摘要整理

  • 市場概要
  • 主要企業
  • 市場趨勢與推動因素
  • 全球市場預測

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他的歐洲
  • 亞太地區
  • 全球其他地區

第4章 競爭

簡介目錄
Product Code: MCP14015

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Plasma Fractionation Market to Reach $36.7 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Plasma Fractionation estimated at US$24.1 Billion in the year 2022, is projected to reach a revised size of US$36.7 Billion by 2030, growing at a CAGR of 5.4% over the analysis period 2022-2030. Immunoglobulins, one of the segments analyzed in the report, is projected to record a 6.8% CAGR and reach US$13.6 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Albumin segment is readjusted to a revised 4.6% CAGR for the next 8-year period.

The U.S. Market is Estimated at $7 Billion, While China is Forecast to Grow at 5% CAGR

The Plasma Fractionation market in the U.S. is estimated at US$7 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$6.4 Billion by the year 2030 trailing a CAGR of 5% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.9% and 4.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4% CAGR.

Select Competitors (Total 47 Featured):

  • Bio Products Laboratory Ltd.
  • Biotest AG
  • China Biologic Products, Inc.
  • CSL Limited
  • Green Cross Corporation
  • Grifols SA
  • Japan Blood Products Organization
  • Kedrion SpA
  • LFB SA
  • Octapharma AG
  • Sanquin
  • Shanghai RAAS Blood Products Co., Ltd.
  • Shire PLC

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Plasma Fractionation: Overview & Outlook
    • Plasma Fractionation - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Intravenous Immunoglobulin Products Gain Traction
    • Rising Incidence of Respiratory Diseases: Major Driver
    • Growing Prevalence of Bleeding Disorders Bodes Well
    • Rise in AATD Cases Steers Demand
    • Advancements in Plasma Collection Technology Favor Growth
    • Recombinant Technology: Key Challenge
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Plasma Fractionation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Plasma Fractionation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 3: World 16-Year Perspective for Plasma Fractionation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Coagulation Factor Concentrates by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Coagulation Factor Concentrates by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 6: World 16-Year Perspective for Coagulation Factor Concentrates by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Albumin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Albumin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 9: World 16-Year Perspective for Albumin by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Protease Inhibitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Protease Inhibitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 12: World 16-Year Perspective for Protease Inhibitors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 15: World 16-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 18: World 16-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Clinical Research Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Clinical Research Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 21: World 16-Year Perspective for Clinical Research Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 24: World 16-Year Perspective for Academic Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 25: World Plasma Fractionation Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Immunoglobulins by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Immunoglobulins by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 28: World 16-Year Perspective for Immunoglobulins by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 31: World 16-Year Perspective for Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Immunology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Immunology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 34: World 16-Year Perspective for Immunology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Hematology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Hematology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 37: World 16-Year Perspective for Hematology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 40: World 16-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Pulmonology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Pulmonology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 43: World 16-Year Perspective for Pulmonology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 46: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Plasma Fractionation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 47: USA Recent Past, Current & Future Analysis for Plasma Fractionation by Product - Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Plasma Fractionation by Product - Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 49: USA 16-Year Perspective for Plasma Fractionation by Product - Percentage Breakdown of Value Sales for Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products for the Years 2014, 2023 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Plasma Fractionation by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Plasma Fractionation by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 52: USA 16-Year Perspective for Plasma Fractionation by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes for the Years 2014, 2023 & 2030
    • TABLE 53: USA Recent Past, Current & Future Analysis for Plasma Fractionation by Application - Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 54: USA Historic Review for Plasma Fractionation by Application - Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 55: USA 16-Year Perspective for Plasma Fractionation by Application - Percentage Breakdown of Value Sales for Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications for the Years 2014, 2023 & 2030
  • CANADA
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Plasma Fractionation by Product - Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Plasma Fractionation by Product - Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 58: Canada 16-Year Perspective for Plasma Fractionation by Product - Percentage Breakdown of Value Sales for Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products for the Years 2014, 2023 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Plasma Fractionation by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Plasma Fractionation by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 61: Canada 16-Year Perspective for Plasma Fractionation by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes for the Years 2014, 2023 & 2030
    • TABLE 62: Canada Recent Past, Current & Future Analysis for Plasma Fractionation by Application - Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 63: Canada Historic Review for Plasma Fractionation by Application - Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 64: Canada 16-Year Perspective for Plasma Fractionation by Application - Percentage Breakdown of Value Sales for Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications for the Years 2014, 2023 & 2030
  • JAPAN
    • Plasma Fractionation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Plasma Fractionation by Product - Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Plasma Fractionation by Product - Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 67: Japan 16-Year Perspective for Plasma Fractionation by Product - Percentage Breakdown of Value Sales for Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products for the Years 2014, 2023 & 2030
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Plasma Fractionation by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Plasma Fractionation by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 70: Japan 16-Year Perspective for Plasma Fractionation by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes for the Years 2014, 2023 & 2030
    • TABLE 71: Japan Recent Past, Current & Future Analysis for Plasma Fractionation by Application - Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 72: Japan Historic Review for Plasma Fractionation by Application - Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 73: Japan 16-Year Perspective for Plasma Fractionation by Application - Percentage Breakdown of Value Sales for Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications for the Years 2014, 2023 & 2030
  • CHINA
    • Plasma Fractionation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 74: China Recent Past, Current & Future Analysis for Plasma Fractionation by Product - Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Plasma Fractionation by Product - Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 76: China 16-Year Perspective for Plasma Fractionation by Product - Percentage Breakdown of Value Sales for Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products for the Years 2014, 2023 & 2030
    • TABLE 77: China Recent Past, Current & Future Analysis for Plasma Fractionation by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Plasma Fractionation by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 79: China 16-Year Perspective for Plasma Fractionation by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes for the Years 2014, 2023 & 2030
    • TABLE 80: China Recent Past, Current & Future Analysis for Plasma Fractionation by Application - Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 81: China Historic Review for Plasma Fractionation by Application - Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 82: China 16-Year Perspective for Plasma Fractionation by Application - Percentage Breakdown of Value Sales for Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications for the Years 2014, 2023 & 2030
  • EUROPE
    • Plasma Fractionation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Plasma Fractionation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Plasma Fractionation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 85: Europe 16-Year Perspective for Plasma Fractionation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Plasma Fractionation by Product - Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Plasma Fractionation by Product - Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 88: Europe 16-Year Perspective for Plasma Fractionation by Product - Percentage Breakdown of Value Sales for Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products for the Years 2014, 2023 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Plasma Fractionation by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Plasma Fractionation by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 91: Europe 16-Year Perspective for Plasma Fractionation by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes for the Years 2014, 2023 & 2030
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Plasma Fractionation by Application - Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for Plasma Fractionation by Application - Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 94: Europe 16-Year Perspective for Plasma Fractionation by Application - Percentage Breakdown of Value Sales for Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications for the Years 2014, 2023 & 2030
  • FRANCE
    • Plasma Fractionation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 95: France Recent Past, Current & Future Analysis for Plasma Fractionation by Product - Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Plasma Fractionation by Product - Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 97: France 16-Year Perspective for Plasma Fractionation by Product - Percentage Breakdown of Value Sales for Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products for the Years 2014, 2023 & 2030
    • TABLE 98: France Recent Past, Current & Future Analysis for Plasma Fractionation by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 99: France Historic Review for Plasma Fractionation by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 100: France 16-Year Perspective for Plasma Fractionation by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes for the Years 2014, 2023 & 2030
    • TABLE 101: France Recent Past, Current & Future Analysis for Plasma Fractionation by Application - Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 102: France Historic Review for Plasma Fractionation by Application - Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 103: France 16-Year Perspective for Plasma Fractionation by Application - Percentage Breakdown of Value Sales for Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications for the Years 2014, 2023 & 2030
  • GERMANY
    • Plasma Fractionation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Plasma Fractionation by Product - Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Plasma Fractionation by Product - Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 106: Germany 16-Year Perspective for Plasma Fractionation by Product - Percentage Breakdown of Value Sales for Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products for the Years 2014, 2023 & 2030
    • TABLE 107: Germany Recent Past, Current & Future Analysis for Plasma Fractionation by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 108: Germany Historic Review for Plasma Fractionation by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 109: Germany 16-Year Perspective for Plasma Fractionation by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes for the Years 2014, 2023 & 2030
    • TABLE 110: Germany Recent Past, Current & Future Analysis for Plasma Fractionation by Application - Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 111: Germany Historic Review for Plasma Fractionation by Application - Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 112: Germany 16-Year Perspective for Plasma Fractionation by Application - Percentage Breakdown of Value Sales for Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications for the Years 2014, 2023 & 2030
  • ITALY
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Plasma Fractionation by Product - Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Plasma Fractionation by Product - Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 115: Italy 16-Year Perspective for Plasma Fractionation by Product - Percentage Breakdown of Value Sales for Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products for the Years 2014, 2023 & 2030
    • TABLE 116: Italy Recent Past, Current & Future Analysis for Plasma Fractionation by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 117: Italy Historic Review for Plasma Fractionation by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 118: Italy 16-Year Perspective for Plasma Fractionation by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes for the Years 2014, 2023 & 2030
    • TABLE 119: Italy Recent Past, Current & Future Analysis for Plasma Fractionation by Application - Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 120: Italy Historic Review for Plasma Fractionation by Application - Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 121: Italy 16-Year Perspective for Plasma Fractionation by Application - Percentage Breakdown of Value Sales for Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
    • Plasma Fractionation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 122: UK Recent Past, Current & Future Analysis for Plasma Fractionation by Product - Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Plasma Fractionation by Product - Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 124: UK 16-Year Perspective for Plasma Fractionation by Product - Percentage Breakdown of Value Sales for Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products for the Years 2014, 2023 & 2030
    • TABLE 125: UK Recent Past, Current & Future Analysis for Plasma Fractionation by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 126: UK Historic Review for Plasma Fractionation by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 127: UK 16-Year Perspective for Plasma Fractionation by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes for the Years 2014, 2023 & 2030
    • TABLE 128: UK Recent Past, Current & Future Analysis for Plasma Fractionation by Application - Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 129: UK Historic Review for Plasma Fractionation by Application - Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 130: UK 16-Year Perspective for Plasma Fractionation by Application - Percentage Breakdown of Value Sales for Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications for the Years 2014, 2023 & 2030
  • REST OF EUROPE
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Plasma Fractionation by Product - Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Plasma Fractionation by Product - Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 133: Rest of Europe 16-Year Perspective for Plasma Fractionation by Product - Percentage Breakdown of Value Sales for Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products for the Years 2014, 2023 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Plasma Fractionation by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Plasma Fractionation by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 136: Rest of Europe 16-Year Perspective for Plasma Fractionation by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes for the Years 2014, 2023 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Plasma Fractionation by Application - Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Plasma Fractionation by Application - Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 139: Rest of Europe 16-Year Perspective for Plasma Fractionation by Application - Percentage Breakdown of Value Sales for Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
    • Plasma Fractionation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Plasma Fractionation by Product - Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Plasma Fractionation by Product - Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 142: Asia-Pacific 16-Year Perspective for Plasma Fractionation by Product - Percentage Breakdown of Value Sales for Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products for the Years 2014, 2023 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Plasma Fractionation by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Plasma Fractionation by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 145: Asia-Pacific 16-Year Perspective for Plasma Fractionation by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes for the Years 2014, 2023 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Plasma Fractionation by Application - Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Plasma Fractionation by Application - Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 148: Asia-Pacific 16-Year Perspective for Plasma Fractionation by Application - Percentage Breakdown of Value Sales for Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications for the Years 2014, 2023 & 2030
  • REST OF WORLD
    • TABLE 149: Rest of World Recent Past, Current & Future Analysis for Plasma Fractionation by Product - Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 150: Rest of World Historic Review for Plasma Fractionation by Product - Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 151: Rest of World 16-Year Perspective for Plasma Fractionation by Product - Percentage Breakdown of Value Sales for Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products for the Years 2014, 2023 & 2030
    • TABLE 152: Rest of World Recent Past, Current & Future Analysis for Plasma Fractionation by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 153: Rest of World Historic Review for Plasma Fractionation by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 154: Rest of World 16-Year Perspective for Plasma Fractionation by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes for the Years 2014, 2023 & 2030
    • TABLE 155: Rest of World Recent Past, Current & Future Analysis for Plasma Fractionation by Application - Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 156: Rest of World Historic Review for Plasma Fractionation by Application - Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 157: Rest of World 16-Year Perspective for Plasma Fractionation by Application - Percentage Breakdown of Value Sales for Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications for the Years 2014, 2023 & 2030

IV. COMPETITION